Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Timelines and rebleeds in patients admitted into neurosurgical care for aneurysmal subarachnoid haemorrhage

View through CrossRef
Abstract Background Mortality and morbidity of aneurysmal subarachnoid haemorrhage (aSAH) remain high, and prognosis is influenced by multiple non-modifiable factors such as aSAH severity. By analysing the chronology of aSAH management, we aim at identifying modifiable factors with emphasis on the occurrence of rebleeds in a setting with 24/7 surgical and endovascular availability of aneurysm repair and routine administration of tranexamic acid. Methods Retrospective analysis of institutional quality registry data of aSAH cases admitted into neurosurgical care during the time period 01 January 2013–31 December 2017. We registered time and mode of aneurysm repair, haemorrhage patterns, course of treatment, mortality and functional outcome. Rebleeding was scored along the entire timeline from ictus to discharge from the primary stay. Results We included 544 patients (368, 67.6% female), aged 58 ± 14 years (range 1–95 years). Aneurysm repair was performed in 486/544 (89.3%) patients at median 7.4 h after arrival and within 3, 6, 12 and 24 h in 26.8%, 44.7%, 73.0% and 96.1%, respectively. There were circadian variations in time to repair and in rebleeds. Rebleeding prior to aneurysm repair occurred in 9.7% and increased with aSAH severity and often in conjunction with patient relocations or interventions. Rebleeds occurred more often during surgical repair outside regular working hours, whereas rebleeds after repair (1.8%) were linked to endovascular repair. Conclusions The risk of rebleed is imminent throughout the entire timeline of aSAH management even with ultra-early aneurysm repair. Several modifiable factors can be linked to the occurrence of rebleeds and they should be identified and optimised within neurosurgical departments.
Title: Timelines and rebleeds in patients admitted into neurosurgical care for aneurysmal subarachnoid haemorrhage
Description:
Abstract Background Mortality and morbidity of aneurysmal subarachnoid haemorrhage (aSAH) remain high, and prognosis is influenced by multiple non-modifiable factors such as aSAH severity.
By analysing the chronology of aSAH management, we aim at identifying modifiable factors with emphasis on the occurrence of rebleeds in a setting with 24/7 surgical and endovascular availability of aneurysm repair and routine administration of tranexamic acid.
Methods Retrospective analysis of institutional quality registry data of aSAH cases admitted into neurosurgical care during the time period 01 January 2013–31 December 2017.
We registered time and mode of aneurysm repair, haemorrhage patterns, course of treatment, mortality and functional outcome.
Rebleeding was scored along the entire timeline from ictus to discharge from the primary stay.
Results We included 544 patients (368, 67.
6% female), aged 58 ± 14 years (range 1–95 years).
Aneurysm repair was performed in 486/544 (89.
3%) patients at median 7.
4 h after arrival and within 3, 6, 12 and 24 h in 26.
8%, 44.
7%, 73.
0% and 96.
1%, respectively.
There were circadian variations in time to repair and in rebleeds.
Rebleeding prior to aneurysm repair occurred in 9.
7% and increased with aSAH severity and often in conjunction with patient relocations or interventions.
Rebleeds occurred more often during surgical repair outside regular working hours, whereas rebleeds after repair (1.
8%) were linked to endovascular repair.
Conclusions The risk of rebleed is imminent throughout the entire timeline of aSAH management even with ultra-early aneurysm repair.
Several modifiable factors can be linked to the occurrence of rebleeds and they should be identified and optimised within neurosurgical departments.

Related Results

Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash Abstract This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Volume of Aneurysmal Subarachnoid Hematoma Measured Quantitatively by 3D Slicer to Predict Symptomatic Cerebral Vasospasm
Volume of Aneurysmal Subarachnoid Hematoma Measured Quantitatively by 3D Slicer to Predict Symptomatic Cerebral Vasospasm
Background and Objectives: Aneurysmal subarachnoid hemorrhage is strongly associated with symptomatic cerebral vasospasm. This study aims to investigate whether a quant...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Neurosurgical education in Egypt and Africa
Neurosurgical education in Egypt and Africa
OBJECTIVEAfrica still significantly lags in the development of neurosurgery. Egypt, located in North Africa, is well-developed in this specialty, with the largest number of neurosu...
Grading the amount of blood on computed tomograms after subarachnoid hemorrhage.
Grading the amount of blood on computed tomograms after subarachnoid hemorrhage.
According to several studies, the amount of subarachnoid blood on the initial computed tomogram of patients with aneurysmal subarachnoid hemorrhage has predictive value with respec...
Elective neurosurgical humanitarian care in a deployed setting
Elective neurosurgical humanitarian care in a deployed setting
OBJECTIVEActive-duty neurosurgical coverage has been provided at Bagram Air Force Base in Afghanistan since 2007. Early operative logs were reflective of a large number of surgical...
Microglia and macrophage phenotypes in intracerebral haemorrhage injury: therapeutic opportunities
Microglia and macrophage phenotypes in intracerebral haemorrhage injury: therapeutic opportunities
Abstract The prognosis of intracerebral haemorrhage continues to be devastating despite much research into this condition. A prominent feature of intracerebral haemo...

Back to Top